Targeted therapy for essential tremor shows promising results in clinical trial

There’s some renewed hope for the most common movement disorder, even more prevalent than Parkinson’s disease. Essential tremor impacts 7 million Americans who navigate their condition without a targeted treatment. Finally, that’s about to change. Unlike Parkinson’s disease, which is tremor at rest, essential tremor presents during action, says Dr. Jill Farmer.